Candidal vulvovaginitis.
Sobel JD.
Clin Obstet Gynecol. 1993 Mar;36(1):153-65. doi: 10.1097/00003081-199303000-00021.
Recurrent vulvovaginal candidiasis.
Sobel JD.
Am J Obstet Gynecol. 2016 Jan;214(1):15-21. doi: 10.1016/j.ajog.2015.06.067. Epub 2015 Jul 9.
Candidiasis (vulvovaginal).
Martin Lopez JE.
BMJ Clin Evid. 2015 Mar 16;2015:0815.
Vulvovaginal candidosis.
Sobel JD.
Lancet. 2007 Jun 9;369(9577):1961-71. doi: 10.1016/S0140-6736(07)60917-9.
Vulvovaginal Candidiasis: A Review of the Evidence for the 2021 Centers for Disease Control and Prevention of Sexually Transmitted Infections Treatment Guidelines.
Nyirjesy P, Brookhart C, Lazenby G, Schwebke J, Sobel JD.
Clin Infect Dis. 2022 Apr 13;74(Suppl_2):S162-S168. doi: 10.1093/cid/ciab1057.
Candida vulvovaginitis.
Sobel JD.
Semin Dermatol. 1996 Mar;15(1):17-28. doi: 10.1016/s1085-5629(96)80014-9.
Recent Advances in Presentation, Diagnosis and Treatment for Mixed Vaginitis.
Qi W, Li H, Wang C, Li H, Zhang B, Dong M, Fan A, Han C, Xue F.
Front Cell Infect Microbiol. 2021 Nov 2;11:759795. doi: 10.3389/fcimb.2021.759795. eCollection 2021.
Treatment of vulvovaginal candidiasis: a review of the literature.
Dovnik A, Golle A, Novak D, Arko D, Takač I.
Acta Dermatovenerol Alp Pannonica Adriat. 2015;24(1):5-7. doi: 10.15570/actaapa.2015.2.
Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species.
Sobel JD, Sobel R.
Expert Opin Pharmacother. 2018 Jun;19(9):971-977. doi: 10.1080/14656566.2018.1476490. Epub 2018 Jun 22.
Global burden of recurrent vulvovaginal candidiasis: a systematic review.
Denning DW, Kneale M, Sobel JD, Rautemaa-Richardson R.
Lancet Infect Dis. 2018 Nov;18(11):e339-e347. doi: 10.1016/S1473-3099(18)30103-8. Epub 2018 Aug 2.
